Flemming assumed the position of Chief Executive Officer on April 30, 2013 and has been a member of the Board since January 2, 2013. He is also Chairman of the Company’s Executive Committee and oversees Research and Development. Flemming assumed the position of Chief Executive Officer on April 30, 2013 and has been a member of the Board since January 2, 2013. He is also Chairman of the Company’s Executive Committee and oversees Research and Development.
Pharmacy